Sign In
Buy NPCE
$12.89
-0.86 (-6.25%)
At Close: Jul 31, 2026
NeuroPace Announces Refocusing of Product Portfolio
04:05pm, Wednesday, 02'nd Apr 2025
-- Beginning of Wind Down of Stereo EEG (SEEG) Distribution Relationship in Q4 2025 -- -- Maintaining 2025 Revenue Guidance -- -- No Change to Long-Range Plan Expectations of Cash Flow Breakeven by th
NeuroPace to Present at the 24th Annual Needham Virtual Healthcare Conference
08:00am, Wednesday, 26'th Mar 2025
MOUNTAIN VIEW, Calif., March 26, 2025 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced tha
NeuroPace, Inc. (NPCE) Q4 2024 Earnings Call Transcript
07:45pm, Tuesday, 04'th Mar 2025
NeuroPace, Inc. (NASDAQ:NPCE ) Q4 2024 Earnings Conference Call March 4, 2025 4:30 PM ET Company Participants Jeremy Feffer - Investor Relations Joel Becker - Chief Executive Officer and Board Member
NeuroPace Reports Fourth Quarter and Full Year 2024 Financial Results
04:05pm, Tuesday, 04'th Mar 2025
-- Record quarterly revenue of $21.5 million in Q4 2024 -- -- Full-year 2025 revenue guidance of $92 to $96 million --
UPDATE – NeuroPace to Present at the Leerink Partners Global Healthcare Conference
09:15pm, Monday, 03'rd Mar 2025
MOUNTAIN VIEW, Calif., March 03, 2025 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced tha
NeuroPace to Present at the Leerink Partners Global Healthcare Conference
04:05pm, Monday, 03'rd Mar 2025
MOUNTAIN VIEW, Calif. , March 03, 2025 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced th
NeuroPace (NPCE) Surges 5.8%: Is This an Indication of Further Gains?
06:15am, Friday, 21'st Feb 2025
NeuroPace (NPCE) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase i
NeuroPace Completes Repurchase of 5.3 Million Shares of Its Common Stock from KCK Ltd.
04:05pm, Thursday, 20'th Feb 2025
MOUNTAIN VIEW, Calif., Feb. 20, 2025 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced it h
NeuroPace to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025
04:05pm, Wednesday, 19'th Feb 2025
MOUNTAIN VIEW, Calif., Feb. 19, 2025 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced it w
MOUNTAIN VIEW, Calif., Feb. 18, 2025 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE) today announced the completion of its previously announced underwritten public offering of 7,475,000 shares of i
NeuroPace Announces Pricing of Public Offering of $65 Million of Common Stock
06:33am, Friday, 14'th Feb 2025
MOUNTAIN VIEW, Calif., Feb. 14, 2025 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE) today announced the pricing of an underwritten public offering of 6,500,000 shares of its common stock at a publ
NeuroPace Announces Proposed Public Offering of $65 Million of Common Stock
04:34pm, Thursday, 13'th Feb 2025
MOUNTAIN VIEW, Calif., Feb. 13, 2025 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE) today announced that it intends to offer and sell, in an underwritten public offering, $65 million of shares of
MOUNTAIN VIEW, Calif., Feb. 03, 2025 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced that
NeuroPace Issues 2025 Financial Guidance Targets
05:15pm, Tuesday, 28'th Jan 2025
– 2025 revenue guidance of $92 million to $96 million – – 2025 gross margin guidance of 73% to 75% – – Three-year targets of 20% revenue CAGR and achievement of cash flow breakeven – M
NeuroPace (NPCE) Soars 9.1%: Is Further Upside Left in the Stock?
06:36am, Wednesday, 22'nd Jan 2025
NeuroPace (NPCE) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase i
